The human caliciviruses (HuCVs) are important causes of gastroenteritis worldwide.
INTRODUCTION
Norovirus (NoV) and sapovirus (SaV) are classified within the Caliciviridae family and are important causes of viral gastroenteritis [Green, 2007] . These small nonenveloped viruses have a single-stranded positive-sense RNA genome, are genetically diverse and NoVs have been shown to have a very low infectious dose [Teunis et al., 2008] . Both NoVs and SaVs are classified into genogroups based on the major capsid protein sequence. Noroviruses and SaVs are each divided into at least five genogroups (G), of which NoV GI, GII and GIV and SaV GI, GII, GIV and GV [Farkas et al., 2004] infect humans.
In healthy individuals human caliciviruses (HuCVs) cause self-limiting disease with resolution of symptoms within 1-6 days followed by a variable period of virus shedding (1-3 weeks) [Rockx et al., 2002] . However, chronic NoV infection has been documented in persons undergoing immunosuppressive therapy as well as in human immunodeficiency virus (HIV)-positive patients [Wingfield et al., 2010; Bok and Green, 2012] . Early HuCV prevalence studies in HIV-seropositive children and/or adults using electron microscopy or enzyme immunoassays (EIA) did not detect any HuCVs or reported low frequencies [Gonzalez et al., 1998; Nakata et al., 1998 ]. More recent investigations that applied molecular-based assays have detected HuCVs in HIV-infected individuals with prevalences ranging from 12% to 20% [RodriguezGuillen et al., 2005; Ayukekbong et al., 2011] . Nevertheless, similar HuCV detection rates were reported in HIV-negative persons, indicating that although HIV-positive individuals are often infected with HuCVs, there is no association between HIV status and HuCV gastroenteritis. Few studies have examined HuCV genotype diversity in HIV-infected patients. In Venezuela the Lordsdale NoV strain (GII.4) and the London/92 SaV strain (GII.1) have been reported in HIV-positive children [Rodriguez-Guillen et al., 2005] . Recently the NoV GII.4, GII.8 and GII.17 strains were identified in non-diarrhoeal stool specimens from HIV-positive adults in Cameroon [Ayukekbong et al., 2011] . In Kenya very little is known about the prevalence of HuCVs and the diversity of the circulating genotypes. From 1991 and 1994, an epidemiological survey in the Nairobi area reported serum antibody prevalence in adults ranging between 60% for NoV GI to 80-90% for NoV GII and SaV [Nakata et al., 1998 ]. In the same study Norwalk virus (GI.1), Mexico virus (GII.3) and Sapporo virus (GI.1) were detected by EIA in stool specimens from infants [Nakata et al., 1998 ].
A significant number of individuals (around 22.9 million) in Africa live with HIV/acquired immunodeficiency syndrome (AIDS) [De Cock et al., 2012] and general diarrhoea is common in HIV-infected individuals. It is therefore important to determine the prevalence of HuCVs and to assess whether the strains circulating in HIV-infected individuals reflect those found in the community. In this study the prevalence and genotype diversity of HuCVs circulating in a group of Kenyan HIVpositive children, with or without diarrhoea, from the year 1999 to 2000 were investigated. were collected from HIV-seropositive children of varying ages but all <14 years of age (mean 6.3) at the Children of God Relief Institute (COGRI) children's home and home-based programme. Diarrhoeal specimens were defined as loose/watery stool whereas non-diarrhoeal specimens were defined as formed stool at the time of collection. These samples had all previously been tested for rotaviruses [Kiulia et al., 2009] , astroviruses [Kiulia et al., 2007] and adenoviruses (AdVs) [Magwalivha et al., 2010] .
MATERIALS AND METHODS

Ethical approval
Specimen preparation and nucleic acid extraction
Stool suspensions (10%) were prepared in ultrapure water and stored at -20°C until nucleic acid extraction. Total nucleic acids were extracted from 200 ml stool suspension using the MagNA Pure LC Total Nucleic Acid Isolation kit (Roche Diagnostics, Mannheim, Germany) on the automated MagNA Pure system (Roche Diagnostics). The nucleic acids were eluted in 50 ml and stored at -70°C until use.
Detection of human caliciviruses
Norovirus GI and GII were detected with published one-step real-time reverse transcription-polymerase chain reaction (RT-PCR) assays targeting the ORF1/ORF2 junction [Mans et al., 2010] . Specimens were screened for NoV GIV [Trujillo et al., 2006; Murray et al., 2013a] and SaV [Chan et al., 2006; Murray et al., 2013b] as previously described.
Genotyping
Norovirus GI and GII strains were genotyped based on nucleotide sequence determination and phylogenetic analysis of the 5'-end of the capsid gene (Region C) using a semi-nested RT-PCR as described previously [Mans et al., 2013] . Briefly, a first round of amplification was performed with primer pairs QNIF4/G1SKR for NoV GI and QNIF2/G2SKR for NoV GII. If no PCR products were obtained after this step, a second amplification was performed using primes G1SKF/G1SKR and G2SKF/ G2SKR. Sapoviruses were genotyped based on partial capsid gene nucleotide sequences (approximately 300 bp) as described previously [Kitajima et al., 2010; Sano et al., 2011; Murray et al., 2013a] . The PCR products were purified with the DNA Clean and Concentrater kit (Zymo Research, Irvine, CA) and directly sequenced with the ABI PRISM BigDye® Terminator v. 3.1 Cycle Sequencing kit on an ABI 3130 automated analyser (Applied Biosystems, Foster City, CA). Nucleotide sequences were edited and analysed using SequencherTM 4.9 (Gene Codes Corporation, Ann Arbor, MI) and BioEdit Sequence Alignment Editor (V.7.0.9.0) [Hall, 1999] .
Phylogenetic analysis
Phylogenetic analysis of NoV GI, GII and SaV was performed in MEGA5 using the neighbour-joining method, validated by 1000 bootstrap replicates as described previously [Murray et al., 2013a] . Genotypes were assigned based on clustering with reference strains in the phylogenetic tree with >70% bootstrap support. The Norovirus Genotyping Tool [Kroneman et al., 2011] was used to confirm the NoV genotype assignment. Nucleotide sequences determined in this study were submitted to GenBank under accession numbers: KF279373-KF279391 (NoV) and KF267740-KF267745 (SaV).
Statistical analysis
Statistical significance was determined by calculating a 2x2 contingency table using the Fischer's Exact test with Graphpad Quickcalcs (www.graphpad.com/quickcalcs/contingency2/). P values < 0.05 were considered statistically significant.
RESULTS
Human CVs were detected in 19% (18/105 NoV, 6/105 SaV) of stool specimens from HIV-positive children from the COGRI children's home and home-based programme in Nairobi, Kenya. NoV GII represented 16/18 (88.8%) of the NoV infections, NoV GI was detected in 1/18 (5.5%) of specimens and a single GI/GII mixed infection was identified. All specimens tested negative for NoV GIV. Sapovirus GI and GII were each detected in 3/6 (50%) specimens (Table I) . Human CVs were detected in 24% of children with diarrhoea and in 16% of children without diarrhoeal symptoms but the difference was not statistically significant (p=0.3130, Table I ). For both NoVs and SaVs, GI and GII were detected at similar frequencies between symptomatic and asymptomatic children.
The co-infections observed between other enteric viruses and HuCVs are summarised in Table II . Up to two different viruses were detected in symptomatic and asymptomatic children, while three viruses were detected only in children with diarrhoea. Co-infections between NoV GII, SaV and AdV were detected most frequently. Overall 12 different genotypes (Table I) were identified in the 20 HuCVpositive specimens. The NoV strains could be classified into seven (1 GI, 6 GII) genotypes (Fig. 1) . Strains GII.2 and GII.4 were detected most often (5/18 specimens each) followed by GI.3 (2), GII.6 (2), GII.12 (2), GII.14 (2) and GII.17 (1). Five different SaV genotypes (GI.1, GI.6, GII.1, GII.2, GII.4) were detected in the six positive specimens with GI.2 being identified in two specimens (Fig. 2) . Out of the five SaV genotypes, GI.2, GII.1 and GII.2 were detected in children with diarrhoea and GI.6 and GII.4 were identified in children without diarrhoea. The different NoV genotypes were found with similar frequencies in diarrhoeal and non-diarrhoeal specimens. In addition, identical NoV strains were detected in both symptomatic and asymptomatic children. GI.3 and GII.14 were identified in the single sample with a NoV mixed infection. There were four mixed infections with NoV GII and SaV, three of which were also co-infected with AdV. Human CV genotypes present in these coinfections included NoV GII.2, GII.4 and GII.14 and SaV GI.2, GI.6 and GII.1. Diverse GI.3 and GII.6 NoV strains were characterised, while the multiple strains from the other genotypes were highly similar or identical (Fig. 1) . The GII.4 strains could not be assigned to a GII.4 variant group by either the neighbour-joining analysis (bootstrap support=64%) shown in Figure 1 or by the online NoV genotyping tool.
The closest match on GenBank, strain AB303929, is the reference strain for the GII.4
Kaiso 2003 variant and the Kenya strains are 98% identical to this sequence over 287 nucleotides of the 5'-end of the capsid gene.
DISCUSSION
Few studies have investigated the prevalence of HuCVs in HIV-infected children using molecular methods. Several research groups have concluded that there is no significant association between HuCVs and diarrhoea in HIV-infected children or adults [Gonzalez et al., 1998; Rodriguez-Guillen et al., 2005] . However, HuCVs were found more frequently in HIV-infected than uninfected children, suggesting that Reported NoV and SaV prevalence rates in paediatric patients with gastroenteritis vary considerably, with NoV ranging from 6-48% (median 14%) [Koopmans, 2008] and SaV ranging from 0.4-19% [Harada et al., 2009; Lorrot et al., 2011] . These studies did not report HIV-status, however it is likely that a negligible portion of the study patients were HIV-seropositive. The HuCV prevalence of 19% (17% NoV, 5.7% SaV) found in this study corresponds to these previously reported rates. The prevalence was lower than that observed in a study in Venezuela where HuCVs were detected in 51% (22/43) of HIV-infected children [Rodriguez-Guillen et al., 2005] .
The Venezuelan study was performed around the same time period (1997-1998) but focused on infants (mean age -19 months) whereas the mean age of the children in the current study was 6.3 years. This may explain the difference in prevalence since higher HuCV positivity rates have been reported in children < 3 years of age [Murata et al., 2007; Phan et al., 2007; Oldak et al., 2012; Trang et al., 2012] . In this study, as well as the Venezuelan study [Rodriguez-Guillen et al., 2005] , HuCVs were more frequently detected in children with diarrhoea than without. However in both studies this difference was not statistically significant. Since in the Kenyan study diarrhoeal and non-diarrhoeal stool specimens were defined as loose/watery stool and formed stool, respectively, HuCV-infected non-diarrhoeal specimens may not all represent asymptomatic infections. At the time of sample collection (1999-2000) prolonged viral shedding was not well established and consequently a defined diarrhoea-free period prior to specimen collection was not incorporated in the study design. In addition, chronic NoV shedding with or without clinical symptoms has been described in immunocompromised patients, such as renal transplant recipients [Schorn et al., 2010] , which could explain similar HuCV prevalences in symptomatic and asymptomatic HIV-infected children. Co-infections between HuCVs and other enteric viruses were associated with diarrhoeal symptoms (p=0.0152). In contrast, a study in Cameroon detected co-infections of up to five enteric viruses in healthy HIVuninfected children [Ayukekbong et al., 2011] . This may suggest that HIV-infected children are more likely to have diarrhoeal symptoms when infected with multiple enteric viruses than HIV-uninfected children. However, since there are no data on bacterial or parasitic infections in these children these cannot be excluded as causes for diarrhoeal symptoms.
The NoV genogroup distribution in HIV-infected children determined in this study reflects the global trends with 89% NoV GII and 5.5% NoV GI and 5.5% mixed infections [Hoa Tran et al., 2013] . Over a period of 17 months, seven NoV genotypes circulated among 18/105 HIV-seropositive children in Nairobi, Kenya. Three of the g l o b a l l y p r e v a l e n t N o V g e n o t y p e s ( G I I . 2 , G I I . 4 , G I I . 6 ) w e r e d e t e c t e d i n t h e s e children. NoV GII.2 and GII.4 each represented 27% of the NoV infections. This is in contrast with other studies from Africa [Sdiri-Loulizi et al., 2009] , Asia [Cheng et al., 2010] , Europe [Puustinen et al., 2012] and South America [Barreira et al., 2010 ] that report GII.4 as the predominant genotype. In this study a single GII.4 variant was detected in the children. This strain is most closely related to the non-epidemic GII.4
Kaiso 2003 variant that circulated in the Netherlands [Siebenga et al., 2007] and Japan during 2002 and 2003 and was subsequently detected in Australia [Eden et al., 2010] and Egypt [Kamel et al., 2009] Tran et al., 2013] were detected in the present study. The other NoV genotypes detected in this study (GI.3, GII.12, GII.14, GII.17) have been reported at low frequencies on several continents [Cheng et al., 2010; Ferreira et al., 2012; Greening et al., 2012; Puustinen et al., 2012] .
The five SaV genotypes identified in this study have all previously been reported in children with gastroenteritis [Phan et al., 2007; Harada et al., 2012; Trang et al., 2012] . Genotypes II.2 and II.4 have also been detected in asymptomatic children in India [Monica et al., 2007] . The SaV strains from Kenya were closely-matched (95-98% nucleotide identity) to SaVs from several other countries, including Denmark (GII.2), Japan and the United Kingdom (GII.4), Russia and Vietnam (GI.6), Taiwan (GI.2) and Thailand (GII.1). Prior to this study, SaV GII.1 was the only SaV genotype which had been characterised from HIV-seropositive children with gastroenteritis [Rodriguez-Guillen et al., 2005] and it was also detected in a symptomatic child in this study. Sapovirus GI.2 was the only genotype which was identified in two specimens and it has recently been reported as a predominant SaV genotype associated with outbreaks and sporadic cases of gastroenteritis in children [Miyoshi et al., 2010; Svraka et al., 2010; Medici et al., 2012] .
The number of HuCV genotypes (7 NoV and 5 SaV) characterised in this study is high compared to the diversity seen in studies with larger sample sizes. A study in
Tunisia involving 788 patients identified eight different NoV genotypes from 128
NoV-positive specimens [Sdiri-Loulizi et al., 2009] . In Brazil, six NoV genotypes were found in 52 NoV-positive specimens from a total of 319 children [Barreira et al., 2010] . With regards to SaV, a study in Japan identified eight different genotypes from 58 SaV-positive specimens over a four-year period [Harada et al., 2012] . In Denmark, a large-scale study (n=1104) on SaVs found six different genotypes in 80
SaV-positive specimens from paediatric patients with gastroenteritis [Johnsen et al., 2009] .
A remarkably high diversity of HuCVs was characterised from a small number of HIV-seropositive children in Kenya. To establish whether this observation is characteristic of co-infection of HIV and HuCVs, further studies including a larger sample size of HIV-infected and uninfected children from a similar socio-economic setting are necessary. An up-to-date investigation would determine whether recently
